Soyoung Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Therapeutic effects of selumetinib on diffuse neurofibroma and optic pathway glioma in neurofibromatosis type 1.
Journal: Journal of neuro-oncology
Published: March 29, 2026
Expanding genetic and clinical spectra of β-tubulinopathies: A Korean study.
Journal: Journal of human genetics
Published: June 14, 2025
MicroRNA-196a increases apoptosis in B cells through downregulation of FOXO1.
Journal: Molecules and cells
Published: December 09, 2024
Spatial distribution of immune cells and their proximity to STING+ cells are associated with survival in glioblastoma.
Journal: Clinical and translational medicine
Published: November 03, 2024
Optimal timeframe for achieving biochemical remission in Crohn's disease patients treated with first-line biologics: A retrospective multicenter study.
Journal: Medicine
Published: October 28, 2024
Temporal trends in obesity and its prognostic impact in Korean patients with inflammatory bowel disease.
Journal: Journal of gastroenterology
Published: October 06, 2024
Beyond CHD7 gene: unveiling genetic diversity in clinically suspected CHARGE syndrome.
Journal: Journal of human genetics
Published: September 05, 2024
Ataluren-Induced Functional Restoration of Neurofibromin in Fibroblasts From Neurofibromatosis Type 1 Patients With Nonsense Mutations.
Journal: MedComm
Published: August 02, 2024
Clinical and molecular characteristics of Korean patients with Kabuki syndrome.
Journal: Journal of human genetics
Published: February 23, 2024
Clinical and genetic characteristics of three patients with congenital insensitivity to pain with anhidrosis: Case reports and a review of the literature.
Journal: Molecular genetics & genomic medicine
Published: January 24, 2024
Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn's disease patients: a retrospective multicenter study.
Journal: BMC gastroenterology
Published: January 19, 2024
A 10-year follow-up of high-dose ambroxol treatment combined with enzyme replacement therapy for neuropathic Gaucher disease.
Journal: American journal of hematology
Published: December 19, 2023
Last Updated: 09/26/2026